In this BioProcess International Interview, Günter Jagschies, Ph.D., GE Healthcare shares his current projects and see the evolution of their products through the emerging markets world, how he sees the evolution of the market over the next five years and the challenge of coming up with new drugs for the market.

For more information on BioProcess International, visit the webpage: [ Ссылка ]

свернуть